Literature DB >> 21471260

Ketamine-etomidate for children undergoing cardiac catheterization.

Madhur Malik1, Vishwas Malik, Sandeep Chauhan, Naresh Dhawan, Usha Kiran.   

Abstract

The purpose of this study was to determine the effects of combined low-dose ketamine and etomidate on hemodynamics during cardiac catheterization in children with congenital cardiac shunts. Sixty children undergoing routine diagnostic cardiac catheterization were included: 30 had a right-to-left shunt, and 30 had a left-to-right shunt. Both groups were given a single dose of etomidate 0.3 mg·kg(-1) with ketamine 1 mg·kg(-1). There were no hemodynamic changes in the group with a right-to-left shunt. In cases of left-to-right shunt, there were significant differences in heart rate, right atrial pressure, mean arterial pressure, mean pulmonary artery pressure, pulmonary artery wedge pressure, and systemic vascular resistance index. Decreases in pulmonary blood flow and pulmonary-systemic shunt ratio were also observed. Further studies are required with dose titration of this anesthetic combination in pediatric patients with congenital heart disease involving a left-to-right shunt.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21471260     DOI: 10.1177/0218492311402132

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  3 in total

1.  Induction of anaesthesia in cyanotic heart diseases: 'Ketomidate' to the rescue!

Authors:  Nupur Dua; Anju R Bhalotra
Journal:  Indian J Anaesth       Date:  2018-03

2.  Dexmedetomidine-propofol vs ketamine-propofol anaesthesia in paediatric and young adult patients undergoing device closure procedures in cardiac catheterisation laboratory: An open label randomised trial.

Authors:  Kunal Tewari; Vishal V Tewari; Subroto K Datta
Journal:  Indian J Anaesth       Date:  2018-07

Review 3.  Etomidate and its Analogs: A Review of Pharmacokinetics and Pharmacodynamics.

Authors:  Beatrijs I Valk; Michel M R F Struys
Journal:  Clin Pharmacokinet       Date:  2021-06-01       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.